As of 12:21pm ET
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 4.25, with a high estimate of 5.80 and a low estimate of 2.50. The median estimate represents a +174.19% increase from the last price of 1.55.
The current consensus among 4 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.